ProtoECGNet: Case-Based Interpretable Deep Learning for Multi-Label ECG Classification with Contrastive Learning.
ProtoECGNet: Case-Based Interpretable Deep Learning for Multi-Label ECG Classification with Contrastive Learning. ArXiv. 2025 May 17.
PMID: 40395940
Computational challenges arising in algorithmic fairness and health equity with generative AI.
Computational challenges arising in algorithmic fairness and health equity with generative AI. Nat Comput Sci. 2025 May 16.
PMID: 40379962
Synthetic data distillation enables the extraction of clinical information at scale.
Synthetic data distillation enables the extraction of clinical information at scale. NPJ Digit Med. 2025 May 10; 8(1):267.
PMID: 40348936
The MI-CLAIM-GEN checklist for generative artificial intelligence in health.
The MI-CLAIM-GEN checklist for generative artificial intelligence in health. Nat Med. 2025 May; 31(5):1394-1398.
PMID: 39915678
Enriched phenotypes in rare variant carriers suggest pathogenic mechanisms in rare disease patients.
Enriched phenotypes in rare variant carriers suggest pathogenic mechanisms in rare disease patients. BioData Min. 2025 Jan 17; 18(1):6.
PMID: 39825393
Leveraging Foundational Models in Computational Biology: Validation, Understanding, and Innovation.
Leveraging Foundational Models in Computational Biology: Validation, Understanding, and Innovation. Pac Symp Biocomput. 2025; 30:702-705.
PMID: 39670407
Phenotypic overlap between rare disease patients and variant carriers in a large population cohort informs biological mechanisms.
Phenotypic overlap between rare disease patients and variant carriers in a large population cohort informs biological mechanisms. medRxiv. 2024 Apr 19.
PMID: 38699301
Disease progression strikingly differs in research and real-world Parkinson's populations.
Disease progression strikingly differs in research and real-world Parkinson's populations. NPJ Parkinsons Dis. 2024 Mar 13; 10(1):58.
PMID: 38480700
Emerging therapeutic drug monitoring technologies: considerations and opportunities in precision medicine.
Emerging therapeutic drug monitoring technologies: considerations and opportunities in precision medicine. Front Pharmacol. 2024; 15:1348112.
PMID: 38545548
Disease progression strikingly differs in research and real-world Parkinson's populations.
Disease progression strikingly differs in research and real-world Parkinson's populations. medRxiv. 2024 Feb 18.
PMID: 38405736